Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.610
+0.060 (1.32%)
At close: Mar 17, 2026, 4:00 PM EDT
4.520
-0.090 (-1.95%)
After-hours: Mar 17, 2026, 5:13 PM EDT
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $269.78 million as of March 17, 2026. Its market cap has increased by 73.10% in one year.
Market Cap
269.78M
Enterprise Value
179.22M
1-Year Change
73.10%
Ranking
Category
Stock Price
$4.61
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $269.78M, an increase of 36.64%. That is a compound annual growth rate of 5.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 269.78M | 15.13% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 285.59M |
| Avalo Therapeutics | 278.90M |
| Abeona Therapeutics | 271.55M |
| Reviva Pharmaceuticals Holdings | 271.09M |
| C4 Therapeutics | 269.32M |
| Polaryx Therapeutics | 266.54M |
| OmniAb | 264.95M |
| Context Therapeutics | 262.77M |